Combined immunosuppressive therapy in adult glomerulonephritis
Ojeda, W.; Cangiano, J.L.; Campos, J.A.; González, R.R.; Vázquez, J.; Muxó, O.R.
Boletin de la Asociacion Medica de Puerto Rico 68(6): 137-140
1976
ISSN/ISBN: 0004-4849 PMID: 779806 Document Number: 700323
Document emailed within 1 workday
Related Documents
Uszyński, L.; Szczecińska, M.; Dudkiewicz, H.; Sliwowski, A. 1978: Acute leukaemia during immunosuppressive therapy of glomerulonephritis Materia Medica Polona. Polish Journal of Medicine and Pharmacy 10(3): 226-227Carcassonne, Y.; Gastaut, J.A.; Blanc, A.P. 1978: Acute leukemia after prolonged immunosuppressive therapy for glomerulonephritis Cancer Treatment Reports 62(7): 1110-1111
Osman, I.; Koc, H.; Ismet, A.; Meral, B.; Hamdi, A.; Nahide, K.; Akin, U. 1995: Combined immunosuppressive therapy in aplastic anaemia Indian Journal of Medical Research 102: 143-146
Bruns, F.J.; Stachura, I.; Adler, S.; Segel, D.P. 1979: Effect of early plasmapheresis and immunosuppressive therapy on natural history of anti-glomerular basement membrane glomerulonephritis: report of a 22-month follow-up Archives of Internal Medicine 139(3): 372-374
Faust-Tinnefeldt, G.; Geissler, H.E.; Mutschler, E. 1977: Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents Arzneimittel-Forschung 27(11): 2153-2157
Ratner, M.I.; Biriukova, L.S.; Makurov, A.I. 1987: Indications and effectiveness of combined therapy in chronic glomerulonephritis Terapevticheskii Arkhiv 59(8): 29-34
Moskaleva, E.S.; Ignatova, M.S.; Korneeva, V.A.; Muromtsev, I.V.; Tsvetkova, E.I.; Parubinovskaia, N.M.; Kharina, E.A.; Katysheva, O.V.; Krivonos, A.V. 1994: Plasmapheresis in the combined therapy of progressive forms of glomerulonephritis Terapevticheskii Arkhiv 66(6): 42-45
Yu, Z.; Zhou, F.; -Fu Ge, L.; Liu, X.-M.; Fang, Y.; Xie, L.; Kong, F.-S.; Song, N.-X. 2013: High-dose immunosuppressive therapy combined with cord blood infusion and non-myeloablative peripheral blood stem cell transplantation for patients with severe aplastic anemia European Review for Medical and Pharmacological Sciences 17(19): 2613-2618
Burd, S.G.; Glukhova, L.I.; Badalian, O.L. 2010: Efficacy and safety of the mono- and combined therapy with oxcarbazepine in adult patients Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(6): 66-69
Couchoud, C.; Laville, M.; Boissel, J.P. 1994: Treatment of extra-membranous glomerulonephritis with immunosuppressive agents or difficulties of meta-analysis in nephrology Therapie 49(3): 171-173
Lewandowska, T.; Juska, D.; Gawlik, Z.; Tyszkiewicz, Z. 1984: Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. V. Purinethol, leukeran, encorton and curantyl Patologia Polska 35(1): 91-103
Eaton, J.W.; Menzies, N.A.; Stover, J.; Cambiano, V.; Chindelevitch, L.; Cori, A.; Hontelez, J.A.C.; Humair, S.; Kerr, C.C.; Klein, D.J.; Mishra, S.; Mitchell, K.M.; Nichols, B.E.; Vickerman, P.; Bakker, R.; Bärnighausen, T.; Bershteyn, A.; Bloom, D.E.; Boily, M-Claude.; Chang, S.T.; Cohen, T.; Dodd, P.J.; Fraser, C.; Gopalappa, C.; Lundgren, J.; Martin, N.K.; Mikkelsen, E.; Mountain, E.; Pham, Q.D.; Pickles, M.; Phillips, A.; Platt, L.; Pretorius, C.; Prudden, H.J.; Salomon, J.A.; van de Vijver, D.A.M.C.; de Vlas, S.J.; Wagner, B.G.; White, R.G.; Wilson, D.P 2014: Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models Lancet. Global health 2(1): e23-e34
Shirakawa, F.; Tanaka, Y.; Oda, S.; Chiba, S.; Suzuki, H.; Eto, S.; Yamashita, U. 1986: Immunosuppressive factors from adult T-cell leukemia cells Cancer Research 46(9): 4458-4462
Rivero, I.; Blythman, H.; Baez, J.R. 1977: Study on the addi;ive effect of thymectomy and immunosuppressive agents in adult mice Revista Clinica Espanola 147(5): 461-465
Nyerges, G.; Mészner, Z.; Gyarmati, E.; Kerpel-Fronius, S. 1987: Acyclovir in the therapy of varicella zoster-caused disease in children undergoing immunosuppressive therapy Orvosi Hetilap 128(40): 2083-2088
Blavy, G.; Touré, Y.I.; Diakhate, L. 1985: Chronic primary glomerulonephritis and serum immunoglobulins in the adult Senegalese Nephrologie 6(4): 203
De Werra, P.; Morel-Maroger, L.; Leroux-Robert, C.; Richet, G. 1973: Glomerulonephritis with diffuse IgA deposits in the mesangium. Study of 96 adult cases Schweizerische Medizinische Wochenschrift 103(21): 761-768
Urakabe, S.; Orita, Y.; Shirai, D.; Fukuhara, Y.; Ando, A. 1975: Prognosis of chronic glomerulonephritis in adult patients estimated on the basis of the Markov process Clinical Nephrology 3(2): 48-53
Rostoker, G.; Pech, M.A.; Del Prato, S.; Petit-Phar, M.; Ben Maadi, A.; Dubert, J.M.; Lang, P.; Weil, B.; Lagrue, G. 1989: Serum IgG subclasses and IgM imbalances in adult IgA mesangial glomerulonephritis and idiopathic Henoch-Schoenlein purpura Clinical and Experimental Immunology 75(1): 30-34
Takamatsu, K.; Ikeda, Y.; Nakauchi, Y.; Kawada, M.; Hashimoto, K.; Furihata, M. 1994: Henoch-Schönlein purpura with rapidly progressive glomerulonephritis and fatal intraperitoneal hemorrhage in an adult Nihon Jinzo Gakkai Shi 36(1): 63-68